PCRX Pacira Pharmaceuticals Inc

Pacira Pharmaceuticals Inc is a specialty and generic drug manufacturing company. The company develops, manufactures, and commercializes pharmaceutical products for use in hospitals and ambulatory surgery centers across the United States.

$53.79  +0.04 (0.07%)
As of 12/03/2021 11:05:09 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  02/03/2011
Outstanding shares:  44,544,489
Average volume:  459,852
Market cap:   $2,373,775,819
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    695127100
ISIN:        US6951271005
Sedol:      B3X26D8
Valuation   (See tab for details)
PE ratio:   38.85
PB ratio:   3.33
PS ratio:   4.62
Return on equity:   8.58%
Net income %:   12.01%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy